Canadian Organization for Rare Disorders - PDFSEARCH.IO - Document Search Engine

Canadian Organization for Rare Disorders
Results: 81

#	Item
31	Summary of the Summit on Access to Drugs for Rare Diseases in Canada Canmore, Alberta, Canada July 20 – 21, 2014 This summit was organized by the Canadian Organization for Rare Disorders. This summary is based on proce Add to Reading List Source URL: raredisorders.ca Language: English - Date: 2014-09-24 10:26:27 Drug discovery Epidemiology Medicine Health economics Healthcare Canadian Organization for Rare Disorders Orphan drug Rare disease Clinical trial Health Pharmacology Pharmaceutical sciences
32	Access to Drugs for Rare Diseases in Canada What is a rare disease? A rare disease is defined in many jurisdictions as a disorder that affects less than one in 2,000 persons. There are over 7,000 known rare diseases, man Add to Reading List Source URL: raredisorders.ca Language: English - Date: 2014-09-24 10:25:57 Pharmaceutical sciences Epidemiology Rare disease Orphan drug Chronic Canadian Organization for Rare Disorders Rare Disease Day Health Medicine Health economics
33	Summit on Access to Drugs for Rare Diseases in Canada Brief Summary Canmore, Alberta, Canada July 20 – 21, 2014 Add to Reading List Source URL: raredisorders.ca Language: English - Date: 2014-09-23 10:26:18 Health Pharmaceutical sciences Medicine Drug discovery Epidemiology Pharmacology Canadian Organization for Rare Disorders Pharmaceuticals policy Canadian Agency for Drugs and Technologies in Health Healthcare in Canada
34	A Canadian Fund for Orphan Drugs? Webinar Consultation August 14, 2014 Recommendations from Canmore Summit Add to Reading List Source URL: raredisorders.ca Language: English - Date: 2014-08-20 12:42:30 Medicine Science Health economics Durhane Wong-Rieger Pharmacology Canadian Organization for Rare Disorders Rieger Clinical trial Rare disease Health Epidemiology Drug discovery
35	Summit on Access to Drugs for Rare Diseases in Canada Brief Summary Canmore, Alberta, Canada July 20 – 21, 2014 Add to Reading List Source URL: raredisorders.ca Language: English - Date: 2014-09-23 10:32:02 Health Pharmaceutical sciences Medicine Drug discovery Epidemiology Pharmacology Canadian Organization for Rare Disorders Pharmaceuticals policy Canadian Agency for Drugs and Technologies in Health Healthcare in Canada
36	Summary of the Summit on Access to Drugs for Rare Diseases in Canada Canmore, Alberta, Canada July 20 – 21, 2014 This summit was organized by the Canadian Organization for Rare Disorders. This summary is based on proce Add to Reading List Source URL: raredisorders.ca Language: English - Date: 2014-09-24 10:25:21 Drug discovery Epidemiology Medicine Health economics Healthcare Canadian Organization for Rare Disorders Orphan drug Rare disease Clinical trial Health Pharmacology Pharmaceutical sciences
37	Access to Drugs for Rare Diseases in Canada What is a rare disease? A rare disease is defined in many jurisdictions as a disorder that affects less than one in 2,000 persons. There are over 7,000 known rare diseases, man Add to Reading List Source URL: raredisorders.ca Language: English - Date: 2014-09-24 10:24:49 Pharmaceutical sciences Epidemiology Rare disease Orphan drug Chronic Canadian Organization for Rare Disorders Rare Disease Day Health Medicine Health economics
38	MOTION!426! AMENDED!MOTION! That “in the opinion of the House, the government should respond specifically to the challenges faced by Canadians with rare diseases and disorders, in collaboration with provinces and terri Add to Reading List Source URL: www.raredisorders.ca Language: English - Date: 2009-03-24 11:08:03 Pharmacology Science Clinical research Clinical trial Design of experiments Pharmaceutical industry Canadian Organization for Rare Disorders Rare disease Mental disorder Epidemiology Health Medicine
39	CANADIAN ORGANIZATION FOR RARE DISORDERS Add to Reading List Source URL: www.raredisorders.ca Language: English - Date: 2010-01-29 12:07:16 Syndromes Thalassemia Beta-thalassemia Prader–Willi syndrome Chelation therapy Iron overload Growth hormone treatment Mucopolysaccharidosis Congenital dyserythropoietic anemia Health Medicine Genetic genealogy
40	Canadian Organization for Rare Disorders Canada’s Orphan Drug Policy Learning from the Best Introduction Canadians suffering from rare debilitating or life threatening diseases need an Orphan Add to Reading List Source URL: www.raredisorders.ca Language: English - Date: 2009-03-24 10:33:39 Pharmaceuticals policy Drug discovery Orphan drug Orphan Drug Act Rare disease Pharmaceutical industry Canadian Organization for Rare Disorders European Organization for Rare Diseases Food and Drug Administration Pharmaceutical sciences Health Pharmacology